Persistence and adherence to Rivastigmine (cas 123441-03-2) in patients with dementia: Results from a noninterventional, retrospective study using the National Health Insurance research database of Taiwan
-
Add time:07/21/2019 Source:sciencedirect.com
IntroductionThe objective of the study was to assess adherence and persistence of patients treated with Rivastigmine (cas 123441-03-2) versus donepezil.
We also recommend Trading Suppliers and Manufacturers of Rivastigmine (cas 123441-03-2). Pls Click Website Link as below: cas 123441-03-2 suppliers
Prev:The synthesis and electrochemical characterization of new metallophthalocyanines containing 4-aminoantipyrine moieties on peripherally positions
Next:Spectrodensitometric determination of Rivastigmine (cas 123441-03-2) after vortex assisted magnetic solid phase extraction) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Controlled delivery of Rivastigmine (cas 123441-03-2) using transdermal patch for effective management of alzheimer's disease07/24/2019
- Paroxetine and Rivastigmine (cas 123441-03-2) mitigates adjuvant-induced rheumatoid arthritis in rats: Impact on oxidative stress, apoptosis and RANKL/OPG signals07/23/2019
- Enhancement of oral bioavailability of Rivastigmine (cas 123441-03-2) with quercetin nanoparticles by inhibiting CYP3A4 and esterases07/22/2019
- Spectrodensitometric determination of Rivastigmine (cas 123441-03-2) after vortex assisted magnetic solid phase extraction07/20/2019
